This protocol covers polycystic liver disease (PLD) in patients who are either entirely asymptomatic or whose symptoms cannot be related to liver volume or to the size or changes of specific cysts.
When PLD is asymptomatic, or when the symptomatology cannot be attributed to liver volume or cyst changes, this distinction directly determines the clinical pathway. The structured protocol specifies the defined clinical stance for this presentation.
In this specific scenario, the protocol addresses the appropriate management stance — access the full evidence-based regimen to see the complete structured approach.
DOI: 10.1016/j.jviscsurg.2018.07.004
When PLD is asymptomatic or if the symptomatology cannot be related to the volume of the liver or the size or changes of certain cysts, therapeutic abstention is the rule.
View source ↗